Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Licenses Pathway Software, Database to Japanese Pharma

NEW YORK (GenomeWeb News) - Pathway informatics firm Ingenuity Systems said today that it has inked a global licensing agreement with Tokyo-based drug maker Astellas Pharma.
 
Under the terms of the agreement, Astellas will use Ingenuity's Pathway Analysis software and will have access to the accompanying Pathway Knowledge Base database, which catalogs information about the relationships between genes, proteins, cells, tissues and diseases.
 
No financial terms of the agreement were released.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.